跳至主要内容
临床试验/NCT01962493
NCT01962493已完成4 期

A Study to Evaluate the Effect of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Digluconate Tooth Staining

GlaxoSmithKline3 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
160
试验地点
3
主要终点
Modified Lobene Stain Index (MLSI) at Week 6

研究概览

简要总结

The aim of this study is to compare the stain effect on teeth of twice daily brushing with a 67% sodium bicarbonate containing toothpaste versus standard toothpaste (not containing sodium bicarbonate) for six weeks whilst using a chlorhexidine digluconate 0.2% mouthwash.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Good oral health in the opinion of the investigator (excluding gingivitis)
  • A minimum of 11 of the 12 permanent gradable anterior teeth at screening
  • Stain levels on the buccal surfaces of the 6 maxillary and 6 mandibular anterior teeth need to be at least "mild" and present on a minimum of 4 teeth
  • Modification of the Lobene Stain Index - At Visit 2, a baseline total MLSI Intensity x Area score (four sites per tooth) of greater than or equal to 8 for facial surfaces of anterior teeth.

排除标准

  • Pregnant women or women who are intending to become pregnant over the duration of the study
  • Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds).
  • Current use of Chlorhexidine, Cetylpyridinium Chloride or any marketed mouthwash
  • Past or current use of any drug which is known to be associated with tooth discolouration within 30 days of screening or during the study period.
  • Recent history (within the last 1 year) of alcohol or other substance abuse
  • Dental conditions / disease requiring immediate treatment; Crowns or veneers on more than one anterior tooth; pre-existing sensitivity to oral care products; severe periodontitis; severe recession; dental implants; active carious lesions on anterior teeth; oral lesions/manifestations; prone to aphthous stomatitis and ulceration etc.
  • Participant with untreated oral mucosal disease which in the opinion of the investigator could interfere with the study.
  • Medical condition which would require the use of prophylactic antibiotics prior to dental cleanings
  • Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any medical disorder that would make the participant unlikely to fully complete the study or any condition that presents undue risk from the study treatment or procedures in the opinion of the investigator or dental assessor.

研究组 & 干预措施

Sodium bicarbonate/ Sodium Fluoride toothpaste

Other

Marketed Sodium bicarbonate toothpaste containing 1400 parts per million (ppm) fluoride as Sodium fluoride (NaF)

干预措施: Sodium bicarbonate/ Sodium Fluoride (Other)

Sodium fluoride toothpaste

Active Comparator

Non-sodium bicarbonate toothpaste containing 1450ppm fluoride as NaF

干预措施: Sodium fluoride (Other)

Chlorhexidine digluconate mouthwash

Other

0.2% w/v Chlorhexidine digluconate mouthwash for rinsing post-brushing with study toothpastes

干预措施: Chlorhexidine digluconate (Drug)

结局指标

主要结局

Modified Lobene Stain Index (MLSI) at Week 6

时间窗: Week 6 post treatment administration

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 6 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score).

次要结局

  • Overall Facial MLSI at Week 6(Week 6 post treatment administration)
  • Overall Gingival and Interproximal MLSI at Week 6(Week 6 post treatment administration)
  • Overall MLSI at Week 3(Week 3 post treatment administration)
  • Overall Facial MLSI at Week 3(Week 3 post treatment administration)
  • Overall Gingival and Interproximal MLSI at Week 3(Week 3 post treatment administration)
  • Overall Interproximal MLSI at Week 3(Week 3 post treatment administration)
  • Overall Interproximal MLSI at Week 6(Week 6 post treatment administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

An Efficacy Study of Stain Control of a 67% Sodium... | 临床试验